COVID19
US FDA approves Gilead's remdesivir as COVID-19 treatment
Washington/Xinhua: The U.S. Food and Drug Administration (FDA) on Thursday approved Gilead Sciences' antiviral drug Veklury (remdesivir) as a treatment for COVID-19.
Previously authorized by the FDA for emergency use to treat COVID-19, Veklury is now the first and only approved COVID-19 treatment in the United States, said Gilead in a statement.
Veklury is indicated for adults and pediatric patients (12 years of age and older and weighing at least 40 kg) for the treatment of COVID-19 requiring hospitalization, Gilead said.
Clinical trials show Veklury shortened time to recovery by five days in hospitalized COVID-19 patients, according to the company.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
